Principal Financial Group Inc Arcutis Biotherapeutics, Inc. Put Options Transaction History
Principal Financial Group Inc
- $162 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ARQT
# of Institutions
172Shares Held
126MCall Options Held
498KPut Options Held
1.64M-
Jennison Associates LLC12.2MShares$117 Million0.08% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$84.3 Million4.57% of portfolio
-
State Street Corp Boston, MA8.78MShares$84.3 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.88MShares$75.6 Million3.34% of portfolio
-
Rubric Capital Management LP New York, NY7.51MShares$72.1 Million2.54% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $578M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...